Meet us at CPHI Milan 2026
Borderless science. Exceptional client-centricity. Discover how Syngene is redefining CRDMO.
- 06-08, October 2026
- Booth #12A33
- Fiera Milano, Italy
Your pipeline, our expertise. Let's talk!
Your molecule. Our expertise. From discovery to commercial.
Bring us your toughest challenge and we will move it faster from molecule to market. Syngene is your fully integrated partner across discovery, development, clinical research, and manufacturing for small, large and niche molecules. We go deep where the pipeline is heading, with proven expertise in antibody drug conjugates, peptides, and oligonucleotides.
Backed by proven manufacturing excellence and a global network across India and the United States, you choose where to build and scale, with the supply chain resilience that protects your timelines and your patients. Meet us at CPHI Milan and see how our science led, client centric partnership turns your ambition into commercial reality.
Siddharth Mittal
Managing Director and CEO
Abhijit Zutshi
Chief Commercial Officer
Dr. Rohtash Kumar
Global Head
CDMO Operations
Andrew Setikas
Global VP
Large Molecule CDMO Business
Julien Hugon
VP
Small Molecule CDMO Business
Manoj Babu
VP
Small Molecule CDMO Business
Rajkumar Agarwal
Associate Vice President
Translational & Clinical Research Business
Vivek Kumaravel
Associate Vice President
Small Molecule CDMO Business
Yogesh Shinde
Associate Vice President
Small Molecule CDMO Business
Pravin Prajapati
Associate Vice President
Large Molecule CDMO Business
Kirit Dhokia
Associate Vice President
Strategic Sourcing
Stephane Lefevre
Technical Sales Director
Oligo & Peptides Business
Mattias Nystrom
Senior Director
Small Molecule CDMO Business
Chetan Ajmera
Chief Procurement & Supply Chain Officer
Rahul Dwivedi
Associate Director
Translational & Clinical Research Business
Pramuch Goel
Head of Corporate Affairs
Sudhir Nambiar
Vice President, Drug Substance Development and Manufacturing
Purushottam Singnurkar
Vice President Pharmaceutical Development
Julien Hugon
Vice President, Business Development
Rajkumar Agarwal
General Manager,
Business Development
Manoj Babu
VP, Development Services
R&D and cGMP manufacturing facilities across the U.S. and India
Bayview, Maryland, U.S.
Mammalian Manufacturing
16 KL (expandable)
Mangalore, India
SM CDMO API manufacturing
~70 KL (expandable)
Biocon Park , Bangalore, India
Mammalian, Microbial, SM API, DP OSD
LM CDMO: 8 KL
SM CDMO: ~70 KL
Unit 3, Bangalore, India
Mammalian, GMP Bioconjugation
LM CDMO: 22 KL (expandable)
DP: Vials, 2 lines, 500 vials/min
Hyderabad, India
India’s first automated compound management facility
R&D center for novel modalities including ADCs, TIDES and PROTACs
The Syngene Advantage
Quality Focus
We are a fully digitized quality organization with a strong compliance track record with global regulators. Our facilities are US FDA, EMA, and PMDA approved, GLP certified, and AAALAC accredited.
Sustainability
As part of our commitment to sustainability, we recycled 63% water, consumed 92% renewable energy, and recycled 95% waste. We had zero environmental violations, and we won the TIME Magazine award for being the most sustainable pharma company in India, and in the Top 20 globally.
Green Chemistry Innovation
Implemented green chemistry across process design, process development, execution, and disposal phases. Also, reduced raw materials, solvents, waste, and disposal.
Robust Supply Chain
A network of 2500+ suppliers across 30+ countries, contracts with global partners, 24X7 local arrangements, and extended support to local partners. Plus, expanded biologics capabilities with our new facility in Bayview, Maryland, U.S.
Brochures
- From Cell Line to Clinic - 4 Months Sooner with mAb Accelerator
- You One Stop Shop for XDCs
- Translational and Clinical Research Services
- Syngene's Biologics Facility in the U.S.
- Translational and Clinical Research
- Partnering for Analytical Excellence
- Your One-Stop-Shop for Biologics
- Partnering for Precision in Small Molecule Drug Substance Development & Manufacturing
- Integrated Oncology Solutions
- Discovery Services
- Accelerating your Success in Antibody Discovery and Engineering
- Transforming Cell Line Development with Syngene's SynWeave Platform
- Next-Gen Modalities, Expertly Enabled
- Syngene Formulation Development Center (FDC)
- Discovery Development Manufacturing - Your Global Partner in Biologics Innovation
We look forward to meeting you in Fiera Milano, Italy.
Let’s shape the future of science together.
Syngene International Limited. All rights reserved © 2026